RACE Concussion Study: Rapid, accurate assessment of blood biomarkers for concussion

Summary

We are investigating if biosensor can accurately measure blood biomarkers of concussion. Concussion diagnoses and prognoses are currently reliant on subjective measures. A biosensor that can objectively measure concussion could supplement subjective measures. This would allow early diagnosis or recovery monitoring to reduce recovery times.

All participants in this study will complete initial visit measures upon enrolment. These include questionnaires (15 minutes) and a blood draw (5 minutes). Participants with concussion will return for follow-up visits at 2, 6, and 12 weeks after injury or until recovery. They will also complete a daily online symptom survey (2 minutes), and be given access to concussion education resources. Participants with a muscular or skeletal injury will only complete initial visit measures.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Inclusion criteria:

1) Concussion OR muskuloskeletal injury (broken bone, pulled muscle, connective tissue damage, etc.) diagnosis within one week before first study visit.
2) Ages 18 through 100 years old

Exclusion criteria:

1) History of neurological diseases (stroke, seizures, epilepsy, dementia, etc.)
2) Current metabolic disease (liver disease, kidney disease, cardiovascular disease, diabetes, etc.)
3) A prior moderate or severe brain injury
4) Any secondary injury during the same time as the concussion or musculoskeletal injury

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Please contact Bianca Perry (student) for more information.

Principal investigator:

Chantel Debert

Clinical trial:

No

REB-ID:

REB22-1015